TriPath Imaging, Inc. engages in the development, manufacture, marketing, and sale of products for cancer detection, diagnosis, staging, and treatment selection. It offers a line of cervical cytology products, including SurePath Test Pack, a liquid-based cytology sample collection, preservation, and transport system; PrepStain Slide Processor, an automated slide preparation system; and FocalPoint Imaging System, a computerized imaging system. The company also offers SlideWizard products. TriPath develops molecular diagnostic products for malignant melanoma, and cancers of the cervix, breast, ovary, and prostate. It also offers microscopic slide based reagents, blood-based reagents, reagent enabling products, and molecular imaging systems. The company offers its solutions primarily to clinical laboratories, clinicians, and third-party payors through its own sales force and distributors. TriPath Imaging was founded in 1996 and is headquartered in Burlington, North Carolina. As of December 20, 2006, TriPath Imaging, Inc. is a subsidiary of Becton Dickinson & Co.